These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27828790)

  • 21. Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway.
    Zhou F; Tan Y; Chen XH; Wu FL; Yang DJ; Zhang XW; Wu XM; Deng YQ
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1142-1149. PubMed ID: 29509268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suxiaojiuxin pill enhances atherosclerotic plaque stability by modulating the MMPs/TIMPs balance in ApoE-deficient mice.
    Zhang J; Zhuang P; Lu Z; Zhang M; Zhang T; Zhang Y; Wang J; Liu D; Tong Y
    J Cardiovasc Pharmacol; 2014 Aug; 64(2):120-6. PubMed ID: 24621651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
    J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasa vasorum and plaque progression, and responses to atorvastatin in a rabbit model of atherosclerosis: contrast-enhanced ultrasound imaging and intravascular ultrasound study.
    Tian J; Hu S; Sun Y; Yu H; Han X; Cheng W; Ban X; Zhang S; Yu B; Jang IK
    Heart; 2013 Jan; 99(1):48-54. PubMed ID: 23100286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of astragali radix extract on matrix metalloproteinase 9 expression and atherosclerotic plaque formation in aorta of apolipoprotein E deficient mice fed with high fat diet].
    You Y; Duan Y; Zhang XL; Kang J; Yan CH; Zhang XL; Feng JT; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):522-6. PubMed ID: 22943650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naoxintong protects against atherosclerosis through lipid-lowering and inhibiting maturation of dendritic cells in LDL receptor knockout mice fed a high-fat diet.
    Zhao J; Zhu H; Wang S; Ma X; Liu X; Wang C; Zhao H; Fan S; Jin X; Zhao B; Zhao T; Jia L; Wang K; Zou Y; Hu K; Sun A; Ge J
    Curr Pharm Des; 2013; 19(33):5891-6. PubMed ID: 23438960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
    Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G
    Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
    Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
    J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atorvastatin treatment and carotid plaque morphology in first-ever atherosclerotic transient ischemic attack/stroke: a case-control study.
    Marchione P; Vento C; Morreale M; Izzo C; Maugeri A; Manuppella F; Romeo T; Giacomini P
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):138-43. PubMed ID: 25440329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice.
    Yang S; Liu M; Chen Y; Ma C; Liu L; Zhao B; Wang Y; Li X; Zhu Y; Gao X; Kong D; Duan Y; Han J; Yang X
    Sci Rep; 2018 Jun; 8(1):9158. PubMed ID: 29904053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased IL-37 in Atherosclerotic Disease could be Suppressed by Atorvastatin Therapy.
    Shaoyuan C; Ming D; Yulang H; Hongcheng F
    Scand J Immunol; 2015 Oct; 82(4):328-36. PubMed ID: 26074195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques.
    Qian C; Wei B; Ding J; Wu H; Cai X; Li B; Wang Y
    Am J Cardiol; 2015 Nov; 116(10):1521-6. PubMed ID: 26385518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
    Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
    J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Establishment of vulnerable plaque model by mast cell activation in adventitia and evaluation of effectiveness of intervention of Shenlian tablet].
    Li YJ; Ruan CX; Yang Q; Weng XG; Chen Y; Wang YJ; Guo Y; Zhou BB; Liu SS; Jiang XH; Zhu XX
    Yao Xue Xue Bao; 2016 Aug; 51(8):1263-70. PubMed ID: 29898356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
    Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
    J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels.
    Bot I; Jukema JW; Lankhuizen IM; van Berkel TJ; Biessen EA
    Atherosclerosis; 2011 Feb; 214(2):295-300. PubMed ID: 21130458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peroxisome proliferator-activated receptor α/γ agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice].
    Zhang BC; Li XK; Che WL; Li WM; Hou L; Wei YD; Xu YW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):143-9. PubMed ID: 23710746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
    Lo J; Lu MT; Ihenachor EJ; Wei J; Looby SE; Fitch KV; Oh J; Zimmerman CO; Hwang J; Abbara S; Plutzky J; Robbins G; Tawakol A; Hoffmann U; Grinspoon SK
    Lancet HIV; 2015 Feb; 2(2):e52-63. PubMed ID: 26424461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.